Literature DB >> 8853781

Cryosurgical ablation of unresectable hepatic tumors.

L M Zuro1, E D Staren.   

Abstract

Ultrasound-guided hepatic cryosurgery is a potential treatment option for select patients with unresectable tumors. Intraoperative placement of cryoprobes and monitoring of tumor freezing with ultrasonography produce complete remission in 22% to 29% of patients with unresectable metastatic colorectal tumors to the liver. Perioperative nurses should be knowledgeable about cryosurgical techniques and be prepared to participate in this innovative treatment modality to provide optimal care to surgical patients.

Entities:  

Mesh:

Year:  1996        PMID: 8853781     DOI: 10.1016/s0001-2092(06)63151-7

Source DB:  PubMed          Journal:  AORN J        ISSN: 0001-2092            Impact factor:   0.676


  4 in total

1.  Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.

Authors:  Timothy M Pawlik; Francesco Izzo; Deborah S Cohen; Jeffery S Morris; Steven A Curley
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

2.  Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma.

Authors:  Yongping Yang; Yinying Lu; Chunping Wang; Wenlin Bai; Jianhui Qu; Yan Chen; Xiujuan Chang; Linjing An; Lin Zhou; Zhen Zeng; Min Lou; Jiyun Lv
Journal:  Exp Ther Med       Date:  2011-12-01       Impact factor: 2.447

3.  High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma.

Authors:  Yong-Ping Yang; Jian-Hui Qu; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Zheng Dong; Hong Wang; Lin-Jing An; Zhong-Xian Xu; Chun-Ping Wang; Zhen Zeng; Ke-Qin Hu
Journal:  J Transl Med       Date:  2013-02-15       Impact factor: 5.531

4.  Cryotherapy is associated with improved clinical outcomes of Sorafenib therapy for advanced hepatocellular carcinoma.

Authors:  Yongping Yang; Yinying Lu; Chunping Wang; Wenlin Bai; Jianhui Qu; Yan Chen; Xiujuan Chang; Linjing An; Lin Zhou; Zhen Zeng; Min Lou; Jiyun Lv
Journal:  Cell Biochem Biophys       Date:  2012-06       Impact factor: 2.194

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.